Comparative Effect of Citalopram and Escitalopram in the Patients with Schizophrenia

Not Applicable

• Conditions: Condition 1: Depression. Condition 2: Schizophrenia.; Major depressive disorder, single episode, mild; Schizophrenia; F32.0

• Registration Number: IRCT20190525043700N1
• Lead Sponsor: Babol University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 November 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Diagnosis of schizophrenia based on DSM-IV TR structured clinical interview by a psychiatrist (faculty member and psychiatry resident)
Diagnosis of depression based on DSM-IV TR structured clinical interview by a psychiatrist (faculty member and psychiatry resident)

Exclusion Criteria

Drug abuse
Epilepsy
Ischemia Heart Disease
Heart Failure
Mental retardation
Parkinson

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patient´s depressive condition. Timepoint: Before intervention (first visit) ,the end of the fourth week (second visit),the end of the eighth week (third visit). Method of measurement: (Calgary Depression Scale for Schizophrenia (CDSS).